|Articles|January 28, 2013

Healthcare Among the Early Leaders as 'Obamacare' Starts to Become a Reality

NEW YORK — Health care stocks have started off the year on a tear.

The industry group that includes health care providers, drugmakers and biotechnology companies has advanced 7.3 percent this year, making it the second-best in the Standard and Poor’s 500 index, trailing only energy companies. Even drugmakers, traditionally considered a safe-haven play, are outperforming the market.

Read the full story: http://wapo.st/10VtFrS

Source: The Washington Post

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Healthcare Among the Early Leaders as 'Obamacare' Starts to Become a Reality

Related Content

Nutrition in Pregnancy May Shape Metabolic Health After Delivery

Social Factors Shape Diabetes, Dementia Risk Across Populations

Why CGM Access and Diabetes Amputations Are Part of the Same Systemic Problem: Alyson K. Myers, MD

Culturally Tailored Diabetes Care Can Improve Outcomes and Reduce Costs: Alyson K. Myers, MD

AI Reshaping Diabetes Care From Nutrition to Clinical Decisions

Trending on AJMC

Emerging Data Suggest Survodutide Targets Liver Fat More Rapidly Than Weight Loss: Lee Kaplan, MD, PhD

Cicada COVID-19 Variant FAQs: Symptoms, Risk, and Prevention

Social Factors Shape Diabetes, Dementia Risk Across Populations

INHALE-1 Findings Support Inhaled Insulin as a Viable Option for Pediatric Patients: Kevin Kaiserman, MD

Survodutide Normalizes Liver Fat in 61% of Patients With MASLD in Phase 3 Trial: Lee Kaplan, MD, PhD